About Trimark
Trimark is a Healthcare company. Pharmaceutical company focused on supplying innovative healthcare products and services globally. Its Indian entity Trimark Pharmaceuticals Private Limited reported revenue of ₹91.6 Lakh. Trimark offers products and services including Pharmaceutical Products and Healthcare Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Innovative Medicines and Services.
Company details
Trimark is viewed as a leading innovation-driven healthcare group with pharmaceuticals as its core business, where products and services are supplied to enhance lives by preventing, diagnosing, and treating diseases. Corporate governance is maintained to meet latest standards, while safety and health of employees and the public are prioritized, along with environmental protection. Sustainable development principles are applied across operations, and a broad portfolio of innovative products is offered through divisions to healthcare professionals worldwide. Commitment to distinguished branded pharmaceuticals is emphasized to improve quality of life.
- SectorsHealthcare
- Email••••••••
- Legal Name Trimark Pharmaceuticals Private Limited
- Date of Incorporation 09 Nov, 2016
- Jurisdiction Hyderabad, Telangana, India
- Indian entity revenue₹91.6 Lakh
FY 2024 · +7% YoY
- Indian entity net profit₹64,414
FY 2024 · 1% margin
- Indian entity EBITDA₹88,299
FY 2024 · 1% margin
Associated legal entities of Trimark
Trimark operates through Trimark Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Trimark Pharmaceuticals Private Limited CIN U74999TG2016PTC112866 | Active | 09 Nov 2016 | Hyderabad, Telangana | ₹0.9 Cr | 4 | View details |
Products & Services of Trimark
Trimark offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Healthcare Services.
Products are supplied by Trimark to improve people's lives through the prevention, diagnosis, and treatment of diseases.
Services are provided by Trimark to support healthcare professionals with a broad portfolio of effective and safe offerings.
Board of directors of Trimark Pharmaceuticals Private Limited (Trimark)
Trimark Pharmaceuticals Private Limited is the primary company behind Trimark. The board of Trimark Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Rajendraprasad Kasarapu, appointed in 2016. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajendraprasad Kasarapu DIN 07651873 | Director | 09 Nov 2016 | 9 yrs 11 mo | Trimark Pharmaceuticals Private Limited |
| Pranitha Kasarapu DIN 07651874 | Director | 09 Nov 2016 | 9 yrs 11 mo | Trimark Pharmaceuticals Private Limited |
| Uday Kumar Akula DIN 10101293 | Director | 06 Apr 2023 | 3 yrs 6 mo | Trimark Pharmaceuticals Private Limited |
| Pavan Kumar Dubba DIN 10099732 | Director | 06 Apr 2023 | 3 yrs 6 mo | Trimark Pharmaceuticals Private Limited |
Financials of Trimark
Figures of Trimark Pharmaceuticals Private Limited, the primary company behind Trimark, for FY 2024. Revenue was ₹91.6 Lakh (+7% year on year). Net profit was ₹64,414 (1% margin). EBITDA was ₹88,299 (1% margin). Revenue has grown at a compounded annual rate of +457% over three years and +26% over five years.
- ₹91.6 LakhRevenue · FY 2024 · +7% YoY
- ₹64,414Net profit · 1% margin
- ₹88,299EBITDA · 1% margin
- ₹3 LakhPaid-up capital
- +457%Revenue CAGR, 3 years
- +26%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Trimark Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Trimark
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trimark
The primary company behind Trimark, Trimark Pharmaceuticals Private Limited, reported revenue of ₹91.6 Lakh for FY 2024, up 7% year on year.
Trimark is viewed as a leading innovation-driven healthcare group with pharmaceuticals as its core business, where products and services are supplied to enhance lives by preventing, diagnosing, and treating diseases. Corporate governance is maintained to meet latest standards, while safety and health of employees and the public are prioritized, along with environmental protection. Sustainable development principles are applied across operations, and a broad portfolio of innovative products is offered through divisions to healthcare professionals worldwide. Commitment to distinguished branded pharmaceuticals is emphasized to improve quality of life.
Trimark offers Pharmaceutical Products and Healthcare Services.
Trimark operates through Trimark Pharmaceuticals Private Limited.
The legal entities of Trimark currently have 4 directors, including Rajendraprasad Kasarapu, Pranitha Kasarapu, Uday Kumar Akula and others.